Search Results
Search for other papers by Nathanael J Yates in
Google Scholar
PubMed
Search for other papers by Dijana Tesic in
Google Scholar
PubMed
Search for other papers by Kirk W Feindel in
Google Scholar
PubMed
Search for other papers by Jeremy T Smith in
Google Scholar
PubMed
Search for other papers by Michael W Clarke in
Google Scholar
PubMed
Search for other papers by Celeste Wale in
Google Scholar
PubMed
Search for other papers by Rachael C Crew in
Google Scholar
PubMed
Search for other papers by Michaela D Wharfe in
Google Scholar
PubMed
Search for other papers by Andrew J O Whitehouse in
Google Scholar
PubMed
Search for other papers by Caitlin S Wyrwoll in
Google Scholar
PubMed
striking changes in lateral ventricle size ( Eyles et al . 2003 , Hawes et al . 2015 ) and marked changes in the dopamine (DA) system ( Kesby et al . 2006 , 2009 , Cui et al . 2010 , 2013 ). However, the generic role that vitamin D has in brain
Search for other papers by Takahiro Nemoto in
Google Scholar
PubMed
Search for other papers by Azusa Iwasaki-Sekino in
Google Scholar
PubMed
Search for other papers by Naoko Yamauchi in
Google Scholar
PubMed
Search for other papers by Tamotsu Shibasaki in
Google Scholar
PubMed
by the pituitary remain unknown. Thus, using primary cultured anterior or intermediate lobe cells of rat pituitary, we examined whether mRNA expression and secretion of pituitary Ucn 2 is affected by CRF, vasopressin, dopamine and glucocorticoids
Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
Search for other papers by Federico Gatto in
Google Scholar
PubMed
Pituitary Center Rotterdam, Erasmus MC, Rotterdam, The Netherlands
Search for other papers by Richard A Feelders in
Google Scholar
PubMed
Search for other papers by Rob van der Pas in
Google Scholar
PubMed
Search for other papers by Peter van Koetsveld in
Google Scholar
PubMed
Search for other papers by Eleonora Bruzzone in
Google Scholar
PubMed
Search for other papers by Marica Arvigo in
Google Scholar
PubMed
Search for other papers by Fadime Dogan in
Google Scholar
PubMed
Search for other papers by Steven Lamberts in
Google Scholar
PubMed
Department of Internal Medicine and & Medical Specialties (DIMI) and Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy
Search for other papers by Diego Ferone in
Google Scholar
PubMed
Pituitary Center Rotterdam, Erasmus MC, Rotterdam, The Netherlands
Search for other papers by Leo Hofland in
Google Scholar
PubMed
mass (the primary cause of the disease). Treatment with somatostatin analogs (SSAs) and/or dopamine agonists (DAs) may result in the inhibition of ACTH secretion by the pituitary adenoma and, therefore, represent attractive drugs for CD treatment
Search for other papers by C Suárez in
Google Scholar
PubMed
Search for other papers by J Vela in
Google Scholar
PubMed
Search for other papers by I García-Tornadú in
Google Scholar
PubMed
Search for other papers by D Becu-Villalobos in
Google Scholar
PubMed
on prolactin and GH secretion in pituitary cells dispersed in vitro , in combination with well-established secretagogues such as angiotensin II (Ang II), dopamine, growth hormone-releasing hormone (GHRH) and somatostatin. Furthermore, we investigated
Search for other papers by Sophie Bernichtein in
Google Scholar
PubMed
Inserm, APHP, Unit 845, Research Center Growth and Signaling, University Paris Descartes, Faculty of Medicine, Necker site, Paris 75015, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
Search for other papers by Vincent Goffin in
Google Scholar
PubMed
loss of libido and infertility in both sexes ( Molitch et al . 1997 ). For 85–90% of patients, this condition is efficiently cured using synthetic analogs of dopamine, the physiological negative regulator of PRL production by lactotrophs ( Molitch 2003
Search for other papers by Omkaram Gangisetty in
Google Scholar
PubMed
Search for other papers by Shaima Jabbar in
Google Scholar
PubMed
Search for other papers by Olivia Wynne in
Google Scholar
PubMed
Search for other papers by Dipak K Sarkar in
Google Scholar
PubMed
Introduction Dopaminergic neurons in the hypothalamus are important regulators of lactotropic cells in the pituitary gland. Dopamine released from these neurons travels to the pituitary gland and acts on D2 receptors located on the lactotropes
Djavad Mowafaghian Centre for Brain Health, The University of British Columbia, Vancouver, British Columbia, Canada
Search for other papers by Daniel J Tobiansky in
Google Scholar
PubMed
Search for other papers by George V Kachkovski in
Google Scholar
PubMed
Search for other papers by Reilly T Enos in
Google Scholar
PubMed
Search for other papers by Kim L Schmidt in
Google Scholar
PubMed
Search for other papers by E Angela Murphy in
Google Scholar
PubMed
Djavad Mowafaghian Centre for Brain Health, The University of British Columbia, Vancouver, British Columbia, Canada
Search for other papers by Stan B Floresco in
Google Scholar
PubMed
Djavad Mowafaghian Centre for Brain Health, The University of British Columbia, Vancouver, British Columbia, Canada
Department of Zoology, The University of British Columbia, Vancouver, British Columbia, Canada
Search for other papers by Kiran K Soma in
Google Scholar
PubMed
mesocorticolimbic system. Sucrose consumption in adolescence alters dopamine receptor levels and decreases dopamine receptor sensitivity in the nucleus accumbens in adulthood ( Naneix et al. 2016 , 2018 ). Sucrose consumption in adolescence also decreases reward
Search for other papers by George Fink in
Google Scholar
PubMed
, Rasheed & Algsham 2012 ). The clue to a possible role of central dopamine came from clinical observations and hypotheses regarding the etiology of Parkinson’s disease and schizophrenia. Thus, as early as 1965, Strang noted an association between Parkinson
Department of Neuroscience and Cell Biology, University of Medicine and Dentistry of NJ, Piscataway, New Jersey 08854, USA
Département de Pharmacologie, Faculté de Mèdecine et Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada JIH 5N4
Search for other papers by Sang-Nam Lee in
Google Scholar
PubMed
Department of Neuroscience and Cell Biology, University of Medicine and Dentistry of NJ, Piscataway, New Jersey 08854, USA
Département de Pharmacologie, Faculté de Mèdecine et Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada JIH 5N4
Search for other papers by Bonnie Peng in
Google Scholar
PubMed
Department of Neuroscience and Cell Biology, University of Medicine and Dentistry of NJ, Piscataway, New Jersey 08854, USA
Département de Pharmacologie, Faculté de Mèdecine et Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada JIH 5N4
Search for other papers by Roxane Desjardins in
Google Scholar
PubMed
Department of Neuroscience and Cell Biology, University of Medicine and Dentistry of NJ, Piscataway, New Jersey 08854, USA
Département de Pharmacologie, Faculté de Mèdecine et Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada JIH 5N4
Search for other papers by John E Pintar in
Google Scholar
PubMed
Department of Neuroscience and Cell Biology, University of Medicine and Dentistry of NJ, Piscataway, New Jersey 08854, USA
Département de Pharmacologie, Faculté de Mèdecine et Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada JIH 5N4
Search for other papers by Robert Day in
Google Scholar
PubMed
Department of Neuroscience and Cell Biology, University of Medicine and Dentistry of NJ, Piscataway, New Jersey 08854, USA
Département de Pharmacologie, Faculté de Mèdecine et Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, Québec, Canada JIH 5N4
Search for other papers by Iris Lindberg in
Google Scholar
PubMed
both 129 and B6 wild-type mice and determined cellular and/or circulating plasma levels of ACTH, α-MSH, β-endorphin, dopamine, and insulin using RIA, and blood glucose levels. Lastly, we have performed ultrastructural analyses of melanotrophs and in
Search for other papers by ELIZABETH A. LINTON in
Google Scholar
PubMed
Search for other papers by NICKI WHITE in
Google Scholar
PubMed
Search for other papers by OFELIA LIRA DE TINEO in
Google Scholar
PubMed
Search for other papers by S. L. JEFFCOATE in
Google Scholar
PubMed
The effects of 2-hydroxyoestradiol (2OH-OE2), dopamine, oestradiol-17β and 2OH-OE2 plus dopamine on prolactin and LH release from the male rat pituitary gland were examined in vitro.
2-Hydroxyoestradiol reduced prolactin secretion by 51% at 10−10 mol/l and by 34% at 10−7 mol/l, while oestradiol-17β had no effect at these doses. Dopamine alone (5 × 10−7 mol/l) decreased prolactin released by 58%, 2OH-OE2 plus dopamine produced a similar inhibition of 60%.
No significant effect on LH release was observed throughout.